Correlation Between Lipocine and Development Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lipocine and Development Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lipocine and Development Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lipocine and Development Technologies Corp, you can compare the effects of market volatilities on Lipocine and Development Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lipocine with a short position of Development Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lipocine and Development Technologies.

Diversification Opportunities for Lipocine and Development Technologies

0.14
  Correlation Coefficient

Average diversification

The 3 months correlation between Lipocine and Development is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Lipocine and Development Technologies Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Development Technologies and Lipocine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lipocine are associated (or correlated) with Development Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Development Technologies has no effect on the direction of Lipocine i.e., Lipocine and Development Technologies go up and down completely randomly.

Pair Corralation between Lipocine and Development Technologies

Given the investment horizon of 90 days Lipocine is expected to generate 8.75 times less return on investment than Development Technologies. But when comparing it to its historical volatility, Lipocine is 1.98 times less risky than Development Technologies. It trades about 0.04 of its potential returns per unit of risk. Development Technologies Corp is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest  375.00  in Development Technologies Corp on September 26, 2024 and sell it today you would earn a total of  537.00  from holding Development Technologies Corp or generate 143.2% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Lipocine  vs.  Development Technologies Corp

 Performance 
       Timeline  
Lipocine 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Lipocine are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady fundamental indicators, Lipocine may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Development Technologies 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Development Technologies Corp are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, Development Technologies exhibited solid returns over the last few months and may actually be approaching a breakup point.

Lipocine and Development Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lipocine and Development Technologies

The main advantage of trading using opposite Lipocine and Development Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lipocine position performs unexpectedly, Development Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Development Technologies will offset losses from the drop in Development Technologies' long position.
The idea behind Lipocine and Development Technologies Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals